AZD4320

AZD4320 Suppliers list
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  
Tel: 18149758185 18149758185
Email: sales-cpd@caerulumpharma.com
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696,15000506266 15000506266
Email:
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: Amadis Chemical Company Limited  
Tel: 571-89925085
Email: sales@amadischem.com
Company Name: Fan De(Beijing) Biotechnology Co., Ltd.  
Tel: 15911056312
Email: liming@bio-fount.com

AZD4320 manufacturers

  • AZD4320
  • AZD4320 pictures
  • $67.00
  • 2026-07-27
  • CAS:1357576-48-7
  • Purity: 98.13%
  • Supply Ability: 10g
  • AZD4320
  • AZD4320 pictures
  • $67.00
  • 2026-07-27
  • CAS:1357576-48-7
  • Purity: 98.13%
  • Supply Ability: 10g
AZD4320 Basic information
Product Name:AZD4320
Synonyms:AZD4320;Benzamide, 4-[4-[(R)-(4'-chloro[1,1'-biphenyl]-2-yl)hydroxymethyl]-1-piperidinyl]-N-[[4-[[(1R)-3-[(2-hydroxyethyl)methylamino]-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]-;Bcl-2 Family,Inhibitor,inhibit,AZD4320,AZD 4320,AZD-4320;4-(4-((R)-(4'-Chloro-[1,1'-biphenyl]-2-yl)(hydroxy)methyl)piperidin-1-yl)-N-((4-(((R)-4-((2-hydroxyethyl)(methyl)amino)-1-(phenylthio)butan-2-yl)amino)-3-((trifluoromethyl)sulfonyl)phenyl)sulfonyl)benzamide;AZD4320, 10 mM in DMSO
CAS:1357576-48-7
MF:C45H48ClF3N4O7S3
MW:945.53
EINECS:
Product Categories:
Mol File:1357576-48-7.mol
AZD4320 Structure
AZD4320 Chemical Properties
density 1.46±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO: 125 mg/mL (132.20 mM)
form Solid
pka4.70±0.10(Predicted)
color White to off-white
Safety Information
MSDS Information
AZD4320 Usage And Synthesis
UsesAZD4320 is a novel BH3-mimicking dual BCL2/BCLxL inhibitor with IC50s of 26 nM, 17 nM, and 170 nM for KPUM-MS3, KPUM-UH1, and STR-428 cells, respectively.
IC 50BCL2: 17 nM (IC50, KPUM-UH1 cells); BCLxL: 17 nM (IC50, KPUM-UH1 cells)
References[1] Takimoto-Shimomura T, et al. Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2. Invest New Drugs. 2018 Jun 21. DOI:10.1007/s10637-018-0623-8
Tag:AZD4320(1357576-48-7) Related Product Information
AZD 4320-d4 AZD4320 AZD8931 ALK/IGF1R inhibitor AZD-5582 AZD-5904